SBC Medical Group Holdings, Inc. Purchases 5 BTC
SBC Medical Group Holdings has announced the completion of its Bitcoin (BTC) purchase of 5 BTC, valued at approximately US$ 0.4 million, on April 14, 2025. This strategic acquisition, initially disclosed on February 12, 2025, is part of the company's financial policy to enhance long-term corporate value and address macroeconomic fluctuations.
The company views Bitcoin as a potential value preservation tool, particularly during inflationary periods, and aims to improve financial stability through diversified investments. SBC Medical, headquartered in Irvine, California and Tokyo, Japan, specializes in providing comprehensive management services to cosmetic treatment center franchises, including marketing, staff management, booking systems, and various operational support services.
SBC Medical Group Holdings ha annunciato il completamento del suo acquisto di Bitcoin (BTC) di 5 BTC, valutati a circa 0,4 milioni di dollari USA, il 14 aprile 2025. Questa acquisizione strategica, inizialmente comunicata il 12 febbraio 2025, fa parte della politica finanziaria dell'azienda per migliorare il valore aziendale a lungo termine e affrontare le fluttuazioni macroeconomiche.
L'azienda considera il Bitcoin come uno strumento potenziale per la preservazione del valore, in particolare durante i periodi di inflazione, e mira a migliorare la stabilità finanziaria attraverso investimenti diversificati. SBC Medical, con sede a Irvine, California e Tokyo, Giappone, è specializzata nella fornitura di servizi di gestione completi per le franchigie di centri di trattamento cosmetico, inclusi marketing, gestione del personale, sistemi di prenotazione e vari servizi di supporto operativo.
SBC Medical Group Holdings ha anunciado la finalización de su compra de Bitcoin (BTC) de 5 BTC, valorados en aproximadamente 0,4 millones de dólares estadounidenses, el 14 de abril de 2025. Esta adquisición estratégica, inicialmente divulgada el 12 de febrero de 2025, es parte de la política financiera de la empresa para mejorar el valor corporativo a largo plazo y abordar las fluctuaciones macroeconómicas.
La empresa ve el Bitcoin como una herramienta potencial para la preservación del valor, especialmente durante períodos inflacionarios, y busca mejorar la estabilidad financiera a través de inversiones diversificadas. SBC Medical, con sede en Irvine, California y Tokio, Japón, se especializa en proporcionar servicios de gestión integral a franquicias de centros de tratamiento estético, incluyendo marketing, gestión del personal, sistemas de reservas y varios servicios de apoyo operativo.
SBC Medical Group Holdings는 2025년 4월 14일 약 40만 달러에 해당하는 5 BTC의 비트코인(BTC) 구매 완료를 발표했습니다. 이 전략적 인수는 2025년 2월 12일 처음 공개되었으며, 회사의 장기 기업 가치를 향상시키고 거시 경제적 변동에 대응하기 위한 재무 정책의 일환입니다.
회사는 비트코인을 특히 인플레이션 기간 동안 가치 보존 도구로 보고 있으며, 다양화된 투자를 통해 재무 안정성을 개선하는 것을 목표로 하고 있습니다. SBC Medical은 캘리포니아주 어바인과 일본 도쿄에 본사를 두고 있으며, 마케팅, 직원 관리, 예약 시스템 및 다양한 운영 지원 서비스를 포함하여 미용 치료 센터 프랜차이즈에 종합 관리 서비스를 제공합니다.
SBC Medical Group Holdings a annoncé l'achèvement de son achat de Bitcoin (BTC) de 5 BTC, d'une valeur d'environ 0,4 million de dollars américains, le 14 avril 2025. Cette acquisition stratégique, initialement divulguée le 12 février 2025, fait partie de la politique financière de l'entreprise visant à améliorer la valeur d'entreprise à long terme et à faire face aux fluctuations macroéconomiques.
L'entreprise considère le Bitcoin comme un outil potentiel de préservation de la valeur, notamment pendant les périodes d'inflation, et vise à améliorer la stabilité financière grâce à des investissements diversifiés. SBC Medical, dont le siège est situé à Irvine, en Californie et à Tokyo, au Japon, se spécialise dans la fourniture de services de gestion complets pour les franchises de centres de traitement esthétique, y compris le marketing, la gestion du personnel, les systèmes de réservation et divers services de soutien opérationnel.
SBC Medical Group Holdings hat den Abschluss seines Bitcoin (BTC)-Kaufs von 5 BTC, die auf etwa 0,4 Millionen US-Dollar geschätzt werden, am 14. April 2025 bekannt gegeben. Dieser strategische Erwerb, der ursprünglich am 12. Februar 2025 bekannt gegeben wurde, ist Teil der Finanzpolitik des Unternehmens, um den langfristigen Unternehmenswert zu steigern und makroökonomischen Schwankungen zu begegnen.
Das Unternehmen betrachtet Bitcoin als potenzielles Mittel zur Werterhaltung, insbesondere in Inflationsphasen, und strebt an, die finanzielle Stabilität durch diversifizierte Investitionen zu verbessern. SBC Medical mit Hauptsitz in Irvine, Kalifornien und Tokio, Japan, ist auf die Bereitstellung umfassender Managementdienste für Franchises von kosmetischen Behandlungszentren spezialisiert, einschließlich Marketing, Personalmanagement, Buchungssystemen und verschiedenen operativen Unterstützungsdiensten.
- Strategic diversification of assets through Bitcoin investment worth US$ 0.4 million
- Implementation of new financial strategy to protect against inflation
- Exposure to volatile cryptocurrency market risks
- Significant capital allocation to speculative asset class
Insights
SBC Medical Group's purchase of 5 Bitcoin (BTC) for approximately
The modest allocation size indicates this is more of an exploratory position than a significant treasury transformation. For context, this
From a practical standpoint, even if Bitcoin were to double in value, the impact on SBC's financial performance would be negligible at roughly
For a medical services company operating in a traditionally conservative sector, this represents a calculated approach to financial innovation while maintaining focus on their core business of managing cosmetic treatment centers. The company appropriately frames this as part of a broader diversification strategy within "a robust risk management framework" rather than a speculative bet.
Investors should view this as a minor treasury management decision that demonstrates forward-thinking financial strategies but with minimal material impact on near-term financial performance or business operations.
IRVINE,Calif., April 14, 2025 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings (Headquarters: California, USA; CEO: Yoshiyuki Aikawa) hereby announces that, based on the announcement of a decision to purchase Bitcoin (BTC) disclosed on February 12, 2025, it has completed its purchase of 5 BTC as of April 14, 2025.
This acquisition is part of our strategic financial policy aimed at responding flexibly and proactively to fluctuations in macroeconomic conditions and enhancing long-term corporate value. Bitcoin is gaining attention as a new means of preserving value, and we recognize its potential to maintain asset value, particularly during inflationary periods, while contributing to improved financial stability through diversified investments. Moving forward, we will continue to adhere strictly to the principle of asset diversification and implement prudent and responsible financial management within a robust risk management framework. While focusing on investments for business growth, we will also establish a financial base aimed at maximizing further revenue through flexible financial strategies, including cryptocurrencies for our available funds.
Information regarding our initiatives and progress will be disclosed on our official website as needed. We kindly request the continued support and understanding of our shareholders and stakeholders.
Details of BTC Purchase
(1) Purchased Cryptocurrency: | Bitcoin (BTC) |
(2) Purchase Amount: | 5 BTC (approx. |
(3) Purchase Date: | April 14, 2025 |
About SBC Medical
SBC Medical, headquartered in Irvine, California and Tokyo, Japan, owns and provides management services and products to cosmetic treatment centers. The Company is primarily focused on providing comprehensive management services to franchise clinics, including but not limited to advertising and marketing needs across various platforms (such as social media networks), staff management (such as recruitment and training), booking reservations for franchise clinic customers, assistance with franchise employee housing rentals and facility rentals, construction and design of franchise clinics, medical equipment and medical consumables procurement (resale), the provision of cosmetic products to franchise clinics for resale to clinic customers, licensure of the use of patent-pending and non-patented medical technologies, trademark and brand use, IT software solutions (including but not limited to remote medical consultations), management of the franchise clinic’s customer rewards program (customer loyalty point program), and payment tools for the franchise clinics.
For more information, visit https://sbc-holdings.com/
Forward Looking Statements
This press release contains forward-looking statements. Forward-looking statements are not historical facts or statements of current conditions, but instead represent only the Company’s beliefs regarding future events and performance, many of which, by their nature, are inherently uncertain and outside of the Company’s control. These forward-looking statements reflect the Company’s current views with respect to, among other things, the Company’s financial performance; growth in revenue and earnings; business prospects and opportunities; and capital deployment plans and liquidity. In some cases, forward-looking statements can be identified by the use of words such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” or “hopes” or the negative of these or similar terms. The Company cautions readers not to place undue reliance upon any forward-looking statements, which are current only as of the date of this release and are subject to various risks, uncertainties, assumptions, or changes in circumstances that are difficult to predict or quantify. The forward-looking statements are based on management’s current expectations and are not guarantees of future performance. The Company does not undertake or accept any obligation to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based, except as required by law. Factors that may cause actual results to differ materially from current expectations may emerge from time to time, and it is not possible for the Company to predict all of them; such factors include, among other things, changes in global, regional, or local economic, business, competitive, market and regulatory conditions, and those listed under the heading “Risk Factors” and elsewhere in the Company’s filings with the U.S. Securities and Exchange Commission (the “SEC”), which are accessible on the SEC’s website at www.sec.gov.
Contact
SBC Medical Group Holdings Incorporated
Hikaru Fukui / Head of Investor Relations
e-mail: ir@sbc-holdings.com
